Sarah Cannon Research Institute is a clinical research site located in Dallas, Texas, United States 75230.
Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.
Sarah Cannon Research Institute has participated in 3 clinical trials with 3 currently active.
Therapeutic areas: Gastrointestinal Stromal Tumor (GIST), Gastrointestinal Stromal Cancer, Gastrointestinal Stromal Neoplasm.
Sponsors: Kura Oncology, Inc., Amgen.
Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Sarah Cannon Research Institute has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Sarah Cannon Research Institute has 3 clinical trials on record, with 3 currently active. Their work covers Gastrointestinal Stromal Tumor (GIST), Gastrointestinal Stromal Cancer, Gastrointestinal Stromal Neoplasm.
Sarah Cannon Research Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.